查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1659393

全球疫苗注射裝置市場

Vaccine Delivery Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球疫苗注射裝置市場規模將達到 66 億美元

2024 年全球疫苗輸送設備市場規模估計為 51 億美元，預計到 2030 年將達到 66 億美元，2024-2030 年分析期間的複合年成長率為 4.4%。注射器是報告中分析的細分市場之一，預計其複合年成長率為 4.4%，到分析期結束時其價值將達到 53 億美元。在分析期內，噴射器部分的複合年成長率預計為 4.8%。

美國市場預計將達到 14 億美元，中國市場複合年成長率將達到 7.5%

預計 2024 年美國疫苗輸送設備市場規模將達 14 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 14 億美元，2024-2030 年分析期間的複合年成長率為 7.5%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 1.2% 和 5.0%。在歐洲，德國的複合年成長率預計為 2.1%。

全球疫苗注射設備市場-主要趨勢與促進因素摘要

什麼是疫苗輸送裝置？

疫苗注射裝置是專門用於安全、有效和準確地注射疫苗的工具或技術。這些設備包括注射器、無針注射器、微針貼片、滴鼻劑、皮內注射器、口服給藥裝置等。它們用於運送各種類型的疫苗，包括去活化疫苗、減毒疫苗、mRNA疫苗、次單位疫苗和病毒載體疫苗，確保疫苗到達適當的組織以獲得最佳免疫反應。這些設備不僅提高了疫苗接種的效率和準確性，而且還提高了患者的依從性，降低了針刺傷的風險並最大限度地減少了浪費。

疫苗輸送裝置的重要性在於它們能夠透過確保安全有效的疫苗接種來支持成功的疫苗接種計劃。有效的疫苗接種對於實現高疫苗接種覆蓋率至關重要，特別是在大規模疫苗宣傳活動和旨在控制感染疾病的公共衛生工作中。自動失效注射器等裝置有助於防止重複使用並降低感染風險，而無針注射器可以提高針頭恐懼症患者對疫苗的接受度。隨著全球疫苗接種需求的成長，特別是針對流行病、常規免疫和應對新興感染疾病的需求，疫苗接種裝置已成為支持及時有效的免疫接種工作的醫療保健基礎設施的重要組成部分。

科技進步如何影響疫苗輸送裝置市場？

科技進步極大地改善了疫苗注射裝置的設計、安全性和效率，促進了世界各地免疫計畫的創新。一項重大進展是微針貼片的引入，它提供了一種無痛、微創的皮內注射疫苗的方法。微針貼片可以塗覆或裝載疫苗並自行使用，這使其成為大規模疫苗宣傳活動和偏遠、資源匱乏環境的理想選擇。這些貼片不需要冷藏，減少了低溫運輸物流並促進了更廣泛地獲得疫苗，特別是在開發中國家。

另一項重大進展是無針注射器的發展。注射器利用高壓將疫苗通過皮膚輸送，無需針頭。這些裝置降低了針刺傷的風險，提高了患者的依從性，並最大限度地減少了生物危害廢棄物。無針注射器用於注射流感、麻疹和肝炎等疫苗，並且正在適應新冠和結核病等新興疫苗。無針系統、自動開閉注射器等技術創新提高了疫苗接種的安全性。這些注射器設計為一次使用後自動鎖定，防止重複使用並降低交叉污染的風險，使其成為安全疫苗接種所必需的，特別是在大規模宣傳活動中。

融入數位技術的智慧配送設備的興起也正在改變市場。智慧型穿戴式注射器可以監測劑量準確性、追蹤管理並收集疫苗接種覆蓋率的即時資料，幫助醫療保健提供者改善免疫計劃和疫苗追蹤。此外，鼻內給藥系統的進步擴大了非侵入性疫苗給藥的選擇，使得流感疫苗等疫苗的給藥變得簡單有效。這些創新不僅提高了疫苗注射裝置的性能和安全性，也符合更容易獲得、更易於使用和永續的免疫解決方案的全球目標。

疫苗輸送裝置在各種免疫計畫中有哪些新興應用？

由於需要更有效、更方便、更安全的疫苗接種方法，疫苗輸送裝置在各種疫苗接種計畫中的應用越來越廣泛。在常規兒童免疫接種計劃中，自動注射器和肌肉內注射器等設備通常用於注射麻疹、白喉和脊髓灰質炎等疾病的疫苗。這些設備確保準確和安全的管理，支持全球實現高免疫覆蓋率和預防疫苗可預防疾病的努力。對於成人疫苗接種計劃，包括流感、肺炎球菌和 COVID-19 疫苗接種，無針注射器和微針貼片正獲得越來越廣泛的支持，因為它們可以更快地進行注射、減輕疼痛并提高患者的依從性，尤其是對於有針頭恐懼症的患者。

為了應對大流行和新興感染疾病，快速、大規模的疫苗接種宣傳活動需要多功能、可擴展的接種解決方案。在新冠肺炎疫情期間，為了有效接種疫苗，人們引入了各種各樣的給藥裝置，從用於肌肉注射疫苗的自動拆卸注射器到方便給藥的鼻腔噴霧劑。 mRNA 疫苗的開發需要專門的遞送技術來保持穩定性和有效性，這也推動了專門注射器和低溫運輸相容設備的採用。狂犬病和結核病等疫苗的皮內注射器的使用越來越廣泛，凸顯了對能夠採用劑量節約策略的設備的需求日益成長，以便在資源有限的環境中最大限度地增加疫苗供應。

癌症疫苗和治療愛滋病毒和肝炎等慢性疾病的疫苗也受益於允許有針對性給藥的創新輸送裝置。例如，在一段可控的時間內透過皮下注射治療性疫苗的穿戴式注射器已成為癌症免疫療法中一種很有前途的解決方案。疫苗接種裝置的多功能性和適應性在這些不同的免疫計劃中發揮關鍵作用，以實現有效的疫苗接種覆蓋率，改善患者治療結果並支持全球衛生舉措。

推動疫苗輸送裝置市場成長的因素是什麼？

疫苗輸送裝置市場的成長受到多種因素的推動，包括全球疫苗接種活動的增加、疫苗研發的進步以及對更安全、更有效的輸送方法的需求。主要成長要素之一將是由於常規免疫計劃、大流行病防範和應對新興感染疾病而對疫苗的需求不斷增加。隨著各國政府和國際組織致力於提高疫苗接種覆蓋率和接種率，對可靠、擴充性的輸送設備的需求正在激增。微針貼片、自毀注射器和無針注射器等技術創新減輕了傳統針頭接種方法帶來的後勤挑戰，並有助於大規模疫苗宣傳活動。

COVID-19 疫苗的快速開發和部署凸顯了對先進給藥裝置的需求，以實現更快的給藥和安全有效的免疫。 mRNA、DNA 和病毒載體疫苗的擴展通常需要專門的遞送技術，這推動了對維持疫苗穩定性和最佳化免疫反應的創新設備的進一步需求。人們越來越關注無針、微創給藥方法，以提高患者的依從性並降低針頭相關風險，這正在加速已開發地區和發展中地區對新型給藥技術的採用。

政府舉措、醫療改革和擴大疫苗接種計劃也促進了市場成長。例如，世界衛生組織（WHO）和聯合國兒童基金會強調使用安全注射技術，並提倡採用自毀注射器和其他安全設計的設備，以防止交叉污染並提高疫苗安全性。此外，居家醫療和分散醫療保健的興起將推動對自我管理疫苗設備（如微針貼片和滴鼻劑）的需求，從而支持更靈活的疫苗接種策略。隨著設備技術、數位整合和永續製造的不斷創新，在全球努力使疫苗更易於取得、更安全和更有效的推動下，疫苗輸送設備市場有望實現強勁成長。

部分

裝置（注射器、噴射注射器、其他裝置）；給藥途徑（肌肉注射、皮下注射、皮內注射、其他給藥途徑）

受訪公司範例（總合42家公司）

  • 3M
  • Becton Dickinson & Company
  • BioJect Medical Technologies, Inc.（Inovio Pharmaceuticals, Inc.）
  • Corium International, Inc
  • Gerresheimer AG
  • Pharmajet, Inc
  • Schott AG
  • Valeritas
  • Vaxxas

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP23010

Global Vaccine Delivery Devices Market to Reach US$6.6 Billion by 2030

The global market for Vaccine Delivery Devices estimated at US$5.1 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in the Jet Injectors segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.5% CAGR

The Vaccine Delivery Devices market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Vaccine Delivery Devices Market - Key Trends & Drivers Summarized

What Are Vaccine Delivery Devices, and Why Are They So Crucial in Modern Immunization?

Vaccine Delivery Devices are specialized tools and technologies designed to administer vaccines safely, effectively, and accurately. These devices include syringes, needle-free injectors, microneedle patches, nasal sprays, intradermal injectors, and oral delivery devices. They are used to deliver various types of vaccines, including inactivated, live-attenuated, mRNA, subunit, and viral vector vaccines, ensuring the vaccines reach the appropriate tissue for optimal immune response. These devices not only improve the efficiency and accuracy of vaccine administration but also enhance patient compliance, reduce the risk of needle-stick injuries, and minimize wastage.

The importance of vaccine delivery devices lies in their ability to support successful immunization programs by ensuring safe and effective vaccine administration. Efficient vaccine delivery is critical for achieving high immunization coverage, especially in mass vaccination campaigns and public health initiatives aimed at controlling infectious diseases. Devices like auto-disable syringes help prevent reuse and reduce infection risks, while needle-free injectors improve vaccine acceptance among needle-phobic populations. As global vaccination needs grow, particularly in response to pandemics, routine immunization, and emerging infectious diseases, vaccine delivery devices have become essential components of healthcare infrastructure, supporting timely and effective immunization efforts.

How Are Technological Advancements Shaping the Vaccine Delivery Devices Market?

Technological advancements have significantly improved the design, safety, and efficiency of Vaccine Delivery Devices, driving innovation across immunization programs worldwide. One of the major developments is the introduction of microneedle patches, which offer a painless, minimally invasive way to deliver vaccines intradermally. Microneedle patches are coated or filled with vaccines and can be self-administered, making them ideal for mass vaccination campaigns, remote locations, and low-resource settings. These patches do not require refrigeration, reducing cold chain logistics and facilitating broader access to vaccines, especially in developing countries.

Another key advancement is in the development of needle-free injectors, which use high-pressure streams to deliver vaccines through the skin without the use of needles. These devices reduce the risk of needle-stick injuries, improve patient compliance, and minimize biohazard waste. Needle-free injectors have been used in administering vaccines for diseases like influenza, measles, and hepatitis, and are being adapted for emerging vaccines, including those for COVID-19 and tuberculosis. In addition to needle-free systems, innovations in auto-disable syringes have improved safety during immunization. These syringes are designed to lock automatically after a single use, preventing reuse and reducing the risk of cross-contamination, making them crucial for safe vaccine administration, especially in mass campaigns.

The rise of smart delivery devices that integrate digital technology is transforming the market as well. Smart syringes and wearable injectors can monitor dosing accuracy, track administration, and collect real-time data on vaccination coverage, helping healthcare providers improve immunization programs and vaccine tracking. Advances in intranasal delivery systems have also expanded the options for non-invasive vaccine administration, offering easy and efficient delivery of vaccines such as the flu vaccine. These technological innovations are not only improving the performance and safety of vaccine delivery devices but also aligning with global goals for more accessible, user-friendly, and sustainable immunization solutions.

What Are the Emerging Applications of Vaccine Delivery Devices Across Different Immunization Programs?

Vaccine Delivery Devices are finding expanding applications across a wide range of immunization programs, driven by the need for more efficient, accessible, and safer vaccination methods. In routine childhood immunization programs, devices like auto-disable syringes and intramuscular injectors are commonly used to deliver vaccines for diseases such as measles, diphtheria, and polio. These devices ensure precise dosing and safe administration, supporting global efforts to achieve high immunization coverage and prevent vaccine-preventable diseases. In adult immunization programs, including influenza, pneumococcal, and COVID-19 vaccinations, needle-free injectors and microneedle patches are gaining traction as they offer faster administration, reduced pain, and improved patient compliance, particularly among needle-phobic individuals.

In response to pandemics and emerging infectious diseases, rapid and large-scale vaccination campaigns require versatile and scalable delivery solutions. During the COVID-19 pandemic, a variety of delivery devices were deployed to ensure efficient vaccine rollout, from auto-disable syringes for intramuscular vaccines to intranasal sprays for easier administration. The development of mRNA vaccines, which require specific delivery techniques to maintain stability and efficacy, has also driven the adoption of specialized injectors and cold-chain-compatible devices. The expanding use of intradermal injectors for vaccines like rabies and tuberculosis highlights the growing demand for devices that allow for dose-sparing strategies, maximizing vaccine supply in resource-limited settings.

Therapeutic vaccines, such as cancer vaccines and those for chronic diseases like HIV and hepatitis, also benefit from innovative delivery devices that provide targeted administration. For example, wearable injectors that deliver therapeutic vaccines subcutaneously over a controlled period have emerged as a promising solution in cancer immunotherapy. The versatility and adaptability of vaccine delivery devices across these diverse immunization programs reflect their critical role in achieving effective vaccination coverage, improving patient outcomes, and supporting global health initiatives.

What Drives Growth in the Vaccine Delivery Devices Market?

The growth in the Vaccine Delivery Devices market is driven by several factors, including increasing global immunization efforts, advancements in vaccine development, and the need for safer and more efficient delivery methods. One of the primary growth drivers is the rising demand for vaccines, fueled by routine immunization programs, pandemic preparedness, and efforts to address emerging infectious diseases. As governments and international organizations focus on improving vaccination rates and coverage, the demand for reliable, scalable delivery devices has surged. Innovations such as microneedle patches, auto-disable syringes, and needle-free injectors have supported mass vaccination campaigns, reducing the logistical challenges associated with traditional needle-based methods.

The rapid development and deployment of COVID-19 vaccines highlighted the critical need for advanced delivery devices that can facilitate faster administration and ensure safe, effective immunization. The expansion of mRNA, DNA, and viral vector vaccines, which often require specialized delivery techniques, has further driven demand for innovative devices that maintain vaccine stability and optimize immune response. The increasing focus on needle-free and minimally invasive delivery methods, which improve patient compliance and reduce needle-associated risks, has accelerated the adoption of new delivery technologies in both developed and developing regions.

Government initiatives, healthcare reforms, and expanded vaccine access programs have also contributed to market growth. For example, the World Health Organization (WHO) and UNICEF have emphasized the use of safe injection practices, promoting the adoption of auto-disable syringes and other safety-engineered devices to prevent cross-contamination and improve vaccine safety. Additionally, the rise of home-based and decentralized healthcare services has increased demand for self-administrable vaccine devices, such as microneedle patches and nasal sprays, supporting more flexible vaccination strategies. With ongoing innovations in device technology, digital integration, and sustainable manufacturing, the Vaccine Delivery Devices market is poised for robust growth, driven by global efforts to enhance vaccine accessibility, safety, and efficiency.

SCOPE OF STUDY:

The report analyzes the Vaccine Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Syringes, Jet Injectors, Other Devices); Route of Administration (Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination, Other Route of Administrations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 3M
  • Becton Dickinson & Company
  • BioJect Medical Technologies, Inc. (Inovio Pharmaceuticals, Inc.)
  • Corium International, Inc
  • Gerresheimer AG
  • Pharmajet, Inc
  • Schott AG
  • Valeritas
  • Vaxxas

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Vaccine Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Vaccine Administration Drives Demand for Vaccine Delivery Devices
    • Advancements in Needle-Free Injection Systems Propel Vaccine Delivery Device Market
    • Expanding Role of Self-Administered Vaccines Sets the Stage for Device Adoption
    • Case Overview: Demand for Single-Use Syringes Enhances Vaccine Delivery Device Market
    • Innovations in Microneedle Technology Generate New Opportunities for Vaccine Devices
    • Focus on Reducing Vaccine Wastage Bodes Well for Delivery Device Adoption
    • Growing Use of Auto-Disable Syringes Sustains Vaccine Delivery Device Market
    • Expanding Role of Prefilled Syringes Enhances Vaccine Delivery Market Growth
    • Push for Improved Immunization Programs Drives Vaccine Delivery Device Adoption
    • Case Overview: Innovations in Smart Syringes Propel Vaccine Delivery Devices
    • Innovations in Intradermal Delivery Propel Vaccine Delivery Device Growth
    • Focus on Mass Immunization Programs Bodes Well for Vaccine Delivery Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Intramuscular Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Intramuscular Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Intramuscular Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Subcutaneous Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Subcutaneous Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Subcutaneous Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Intradermal Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Intradermal Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Intradermal Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • JAPAN
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • CHINA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • EUROPE
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vaccine Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • FRANCE
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • GERMANY
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vaccine Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • INDIA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vaccine Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vaccine Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • AFRICA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030

IV. COMPETITION